Indeed, glucose consumption by tumors and macrophages metabolically impairs T cells, leading to their reduced mTOR activity, glycolytic capacity and IFN-γ production, thereby allowing tumor progression [42]. The gene discussed is MTOR; the disease is neoplasm.